(Q74601358)

English

Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Study Group of Japan for Treatment of Advanced Neuroblastoma, Tokyo, Japan

scientific article published on 01 July 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Study Group of Japan for Treatment of Advanced Neuroblastoma, Tokyo, Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M Kaneko

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

H Nishihira

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

H Mugishima

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

N Ohnuma

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

K Nakada

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

K Kawa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Fukuzawa

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S Suita

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Y Sera

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Y Tsuchida

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese Study Group for the Treatment of Advanced Neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Treatment combined with bone marrow transplantation for advanced neuroblastoma: an analysis of patients who were pretreated intensively with the protocol of the Study Group of Japan

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the Study Group of Japan

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Expression of multidrug resistance-related P-glycoprotein shows good prognosis in neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Human neuroblastoma cell lines that express N-myc without gene amplification.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Immunohistochemical analysis of N-myc protein expression in neuroblastoma: correlation with prognosis of patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Histopathologic findings of advanced neuroblastoma after intensive induction chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Dose-intensive use of cyclophosphamide in ablation of neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199807%2931%3A1%3C1%3A%3AAID-MPO1%3E3.0.CO%3B2-H

21 January 2018

Identifiers

10.1002/(SICI)1096-911X(199807)31:1<1::AID-MPO1>3.0.CO;2-H

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9607422%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74601358&oldid=2218657657"